← Leaderboards
William J Schirmer
Ohio State University
$242,494
Attributed
$242,494
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$242,494 · 2
By mechanism
M01$242,494 · 2
Top collaborators
No co-investigators on record.
Most similar at Ohio State University
Same institution · by research overlap
- Sissy M Jhiang$8,729,538
- Matthew D Ringel$21,305,885
- Mauro Ferrari$18,839,277
- Balveen Kaur$17,543,202
- Kirk A Mykytyn$2,487,945
Others in their field
Top investigators on “Somatostatin”
- Norman Wolmark · Nsabp Foundation, Inc.$52,338,276
- Alan D Cherrington · Vanderbilt University$12,498,973
- Jorge J Palop · J. David Gladstone Institutes$10,746,653
- Johannes D Veldhuis · University Of Virginia Charlottesville$9,450,586
- Nicholas C. Brecha · University Of California Los Angeles$8,938,423
- Gordon J Fishell · Harvard Medical School$8,724,508
Research focus
SomatostatinClinical ResearchHuman SubjectHuman Therapy EvaluationOctreotideDrug Administration RoutesDrug Screening /EvaluationGastrointestinal NeoplasmsHormone TherapyCentral Nervous System NeoplasmsRadiotracerIodineNeoplasm /Cancer ChemotherapyNeoplasm /Cancer DiagnosisNeoplasm /Cancer SurgeryNeural CrestDiagnosis Design /EvaluationDosageDrug Administration Rate /Duration
Grant awards (4)
PHASE III STUDY OF EFFICACY OF DOSE LEVELS OF SANDOSTATIN LAR5$193,916
M01 · FY2001 · RR
PHASE III STUDY OF EFFICACY OF DOSE LEVELS OF SANDOSTATIN LAR5$48,578
M01 · FY2000 · RR
NEURAL CREST TUMORS--BIOLOGY AND THERAPEUTICS$0
M01 · FY2000 · RR
NEURAL CREST TUMORS--BIOLOGY AND THERAPEUTICS$0
M01 · FY2000 · RR